OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: UHN-Krembil

1 Projects | 1 Researchers | $599,811 Invested

2023

UHN-Krembil

Donald Weaver, MD, PhD

Discovery of TRPM2 Inhibitors for the Treatment of Neuroinflammation

  • Funding Amount: $599,811
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Inflammation
  • Status: Active